CAPTRUST Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.63M Sell
10,723
-3,565
-25% -$1.87M 0.01% 591
2025
Q1
$9.06M Buy
14,288
+4,372
+44% +$2.77M 0.02% 452
2024
Q4
$7.06M Buy
9,916
+786
+9% +$560K 0.02% 459
2024
Q3
$9.6M Buy
9,130
+296
+3% +$311K 0.03% 390
2024
Q2
$9.29M Sell
8,834
-65
-0.7% -$68.3K 0.03% 368
2024
Q1
$8.56M Sell
8,899
-3,645
-29% -$3.51M 0.03% 371
2023
Q4
$11M Buy
12,544
+83
+0.7% +$72.9K 0.04% 351
2023
Q3
$10.3M Buy
12,461
+387
+3% +$318K 0.04% 333
2023
Q2
$8.68M Sell
12,074
-328
-3% -$236K 0.03% 358
2023
Q1
$10.2M Sell
12,402
-271
-2% -$223K 0.04% 293
2022
Q4
$9.14M Buy
12,673
+1,204
+10% +$869K 0.05% 308
2022
Q3
$7.9M Buy
11,469
+822
+8% +$566K 0.05% 305
2022
Q2
$6.29M Buy
10,647
+1,189
+13% +$703K 0.04% 328
2022
Q1
$6.61M Sell
9,458
-446
-5% -$312K 0.04% 305
2021
Q4
$6.26M Buy
9,904
+3,375
+52% +$2.13M 0.04% 313
2021
Q3
$3.95M Buy
6,529
+4,636
+245% +$2.81M 0.03% 369
2021
Q2
$1.06M Buy
1,893
+4
+0.2% +$2.23K 0.01% 700
2021
Q1
$894K Buy
1,889
+30
+2% +$14.2K 0.01% 736
2020
Q4
$898K Sell
1,859
-261
-12% -$126K 0.01% 644
2020
Q3
$1.2M Buy
2,120
+432
+26% +$245K 0.02% 453
2020
Q2
$1.03M Buy
1,688
+192
+13% +$117K 0.02% 491
2020
Q1
$743K Buy
1,496
+761
+104% +$378K 0.02% 480
2019
Q4
$274K Buy
735
+527
+253% +$196K ﹤0.01% 873
2019
Q3
$58K Buy
208
+126
+154% +$35.1K ﹤0.01% 946
2019
Q2
$26K Buy
82
+25
+44% +$7.93K ﹤0.01% 1201
2019
Q1
$23K Sell
57
-23
-29% -$9.28K ﹤0.01% 1131
2018
Q4
$30K Buy
+80
New +$30K ﹤0.01% 901
2018
Q1
Sell
-5
Closed -$2K 1370
2017
Q4
$2K Buy
+5
New +$2K ﹤0.01% 1186